Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of Evogliptin 5 mg and Pioglitazone 30 mg
Status:
Completed
Trial end date:
2017-03-10
Target enrollment:
Participant gender:
Summary
A randomized, open-label, multiple dosing, three-way crossover clinical trial to investigate
the pharmacokinetic/pharmacodynamic drug-drug interaction of evogliptin 5 mg and pioglitazone
30 mg after oral administration in healthy male subjects